November 2012, Royal Tunbridge Wells, epg Health Media, announced the debut of the prostate cancer knowledge center, their newest interactive training resource for medical professionals, which is available for immediate distribution. The goal of this astellas pharma europe ltd-sponsored website is to provide urologists, general practitioners, oncologists, and other medical professionals access to the most recent data about prostate cancer. The knowledge center is accessible via the internal medicine, men’s health, and cancer sections of epg online (www.epgonline.org), a website that offers free educational resources for medical professionals. Prostate cancer is the most common cancer diagnosed in European males, apart from skin cancers, with approximately 385,500 new cases identified in 2008[1].Consequently, prostate cancer is a significant contributor to morbidity, particularly in the industrialized world [2]. The website will include details on the latest screening and diagnostic techniques for prostate cancer, as well as suggested treatment choices for specific individuals, including both hormone-sensitive and castrate-resistant forms of the disease. According to Chris Cooper, executive director of epg health media, staying current with current disease processes and treatments is a crucial requirement and challenge for doctors. We are happy to collaborate with Astellas Pharma Europe Ltd. to provide this invaluable resource to epg online users at no cost. The independent website epg online, also known as the professional channel for physicians, is devoted to giving medical professionals up-to-date information about illnesses and treatments. Within 50 disease-specific subject categories, physicians may access medication information (available in nine European languages), results from clinical trials, treatment recommendations, news, journal articles, multimedia, and other material from reliable sources. concludes editor notes about ePG online Epg Online is the biggest free illness and medication website for physicians in Europe, with over 110,000 pages of material. The website is run by epg health media, a digital health publisher committed to giving physicians everywhere access to a top-notch learning environment. Please visit www.epghealthmedia.com for further information on epg health media. with reference to Astellas Pharma Europe Ltd. Tokyo-based Astellas Pharma Inc.’s European headquarters is called astellas Pharma Europe Ltd. and it is situated in the United Kingdom. Astellas is a global pharmaceutical corporation committed to enhancing global health by offering novel and dependable pharmaceutical products. The organization’s goal is to provide excellent marketing and research and development so that it may keep expanding in the global pharmaceutical industry. Astellas Pharma Europe Ltd. is in charge of three production facilities, one R&D facility, and 21 affiliate offices spread around Europe, the Middle East, and Africa. In these areas, the corporation employs around 4,300 people. Please visit www.astellas.eu for further information on Astellas Pharma Europe. references 1. estimations of the global cancer burden in 2008 by Ferlay J, Shin H-R, Brady F, Forman D, Mathers C, and Parkin D. M. Int J Cancer 2010;127(12):2893–2917; Globocan 2008. 2. estimates of cancer incidence and death in Europe in 2006 by Ferlay J, Autier P, Boniol M, Heanue M, Columbet M, Boyle P. Date of preparation: September 2012, egd/12/0016/eug; Ann Oncol 2007;18:581-92 created by epg online with financial assistance from Astellas Pharma Europe Ltd. and in collaboration with them
I love myBlogd
Author
jackemails@gmail.com